The story of Sildenafil presents a interesting case for stakeholders in the drug sector. While initially a blockbuster success, creating huge profits, the exclusivity end and the subsequent arrival of off-brand https://viagra092723.blogscribble.com/42015772/the-little-copyright-and-the-pharmaceutical-industry-a-hazardous-play